Literature DB >> 20223229

In vivo reactivation by oximes of inhibited blood, brain and peripheral tissue cholinesterase activity following exposure to nerve agents in guinea pigs.

Tsung-Ming Shih1, Jacob W Skovira, John C O'Donnell, John H McDonough.   

Abstract

This study compared the ability of nine oximes (HI-6, HLö7, MMB-4, TMB-4, carboxime, ICD585, ICD692, ICD3805, and 2-PAM) to reactivate in vivo cholinesterase (ChE) in blood, brain, and peripheral tissues in guinea pigs intoxicated by one of four organophosphorus nerve agents. Two bis-pyridinium compounds without an oxime group, SAD128 and ICD4157, served as non-oxime controls. Animals were injected subcutaneously with 1.0 x LD(50) of the nerve agents sarin, cyclosarin, VR or VX and treated intramuscularly 5 min later with one of these oximes. Toxic signs and lethality were monitored; tissue ChE activities were determined at 60 min after nerve agent. Some animals exposed to sarin or cyclosarin, with or without non-oxime treatment, died within 60 min; however, no animal treated with an oxime died. For VR or VX, all animals survived the 60 min after exposure, with or without non-oxime or oxime therapy. The four nerve agents caused differential degrees of inhibition in blood, brain regions and peripheral tissues. The tested oximes exhibited differential potency in reactivating nerve agent-inhibited ChE in various peripheral tissues, but did not affect ChE activity in the brain regions. There was no direct relation between blood and peripheral tissues in the reactivating efficacy of oxime treatments. ChE inhibited by sarin was the most susceptible to oxime reactivation while cyclosarin the least susceptible. There was no difference in the ChE reactivating potency between the dimethanesulfonate and dichloride salts of HI-6. MMB-4 significantly reactivated the ChE inhibited by these four nerve agents in blood and all three peripheral tissues of the guinea pig, and among all the oximes tested it was the most effective in vivo ChE reactivator against all four nerve agents. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223229     DOI: 10.1016/j.cbi.2010.03.006

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  16 in total

1.  Intranasal delivery of obidoxime to the brain prevents mortality and CNS damage from organophosphate poisoning.

Authors:  Jishnu K S Krishnan; Peethambaran Arun; Abhilash P Appu; Nivetha Vijayakumar; Taíza H Figueiredo; Maria F M Braga; Sudikshya Baskota; Cara H Olsen; Natalia Farkas; John Dagata; William H Frey; John R Moffett; Aryan M A Namboodiri
Journal:  Neurotoxicology       Date:  2016-01-02       Impact factor: 4.294

2.  Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates.

Authors:  Francine S Katz; Stevan Pecic; Timothy H Tran; Ilya Trakht; Laura Schneider; Zhengxiang Zhu; Long Ton-That; Michal Luzac; Viktor Zlatanic; Shivani Damera; Joanne Macdonald; Donald W Landry; Liang Tong; Milan N Stojanovic
Journal:  Chembiochem       Date:  2015-09-09       Impact factor: 3.164

3.  Influence of gauche effect on uncharged oxime reactivators for the reactivation of tabun-inhibited AChE: quantum chemical and steered molecular dynamics studies.

Authors:  Shibaji Ghosh; Kalyanashis Jana; Bishwajit Ganguly
Journal:  J Comput Aided Mol Des       Date:  2018-07-06       Impact factor: 3.686

4.  Pharmacology, Pharmacokinetics, and Tissue Disposition of Zwitterionic Hydroxyiminoacetamido Alkylamines as Reactivating Antidotes for Organophosphate Exposure.

Authors:  Rakesh K Sit; Zrinka Kovarik; Nikolina Maček Hrvat; Suzana Žunec; Carol Green; Valery V Fokin; K Barry Sharpless; Zoran Radić; Palmer Taylor
Journal:  J Pharmacol Exp Ther       Date:  2018-09-06       Impact factor: 4.030

5.  Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases.

Authors:  Zoran Radić; Rakesh K Sit; Zrinka Kovarik; Suzana Berend; Edzna Garcia; Limin Zhang; Gabriel Amitai; Carol Green; Bozica Radić; Valery V Fokin; K Barry Sharpless; Palmer Taylor
Journal:  J Biol Chem       Date:  2012-02-16       Impact factor: 5.157

Review 6.  Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures.

Authors:  Charles M Thompson; John M Gerdes; Henry F VanBrocklin
Journal:  Neurobiol Dis       Date:  2019-04-22       Impact factor: 5.996

7.  Chronic Treatment with Naltrexone Prevents Memory Retention Deficits in Rats Poisoned with the Sarin Analog Diisopropylfluorophosphate (DFP) and Treated with Atropine and Pralidoxime.

Authors:  Kori L Brewer; Tuan Tran; William J Meggs
Journal:  J Med Toxicol       Date:  2015-12

8.  Alpha-Linolenic Acid-Induced Increase in Neurogenesis is a Key Factor in the Improvement in the Passive Avoidance Task After Soman Exposure.

Authors:  Tetsade C B Piermartiri; Hongna Pan; Jun Chen; John McDonough; Neil Grunberg; James P Apland; Ann M Marini
Journal:  Neuromolecular Med       Date:  2015-04-29       Impact factor: 3.843

9.  Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates.

Authors:  Janice E Chambers; Edward C Meek; Howard W Chambers
Journal:  Ann N Y Acad Sci       Date:  2016-05-06       Impact factor: 5.691

10.  A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides.

Authors:  Christina M Wilhelm; Thomas H Snider; Michael C Babin; David A Jett; Gennady E Platoff; David T Yeung
Journal:  Toxicol Appl Pharmacol       Date:  2014-10-31       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.